Skip to main content

Table 2 Distribution of Ki-67 diagnostic category and RS result among all samples with N1 status confirmed (n = 298)

From: Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer

RS group, n (%)

All samples, N1 (n = 298)

Ki-67 diagnostic category

Negative

Positive

Total

0–25

164 (75)

54 (25)

218

26–100

23 (29)

57 (71)

80

Total

187 (63)

111 (37)

298

31–1001

5 (11)

40 (89)

N/A

  1. n, sample size; N/A, not applicable, as this is a subset of the 26–100 RS group, N1, 1–3 Positive lymph nodes; RS, Recurrence Score®
  2. 1A subset of RS group 26–100
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us